GlassScriptPhysician profile
Paula M Novelli
NPI 1225003957
$13,984.50
in general payments reported to CMS, 2019-2025
10 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,036 · 2022: $388 · 2023: $1,683 · 2024: $294 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,960.00 |
| Food and Beverage | $600.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $12,340.49 | 2022-2025 | Viatorr Endoprosthesis, Tips Set, Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Biocompatibles, INC. | $948.91 | 2019 | |
| Boston Scientific Corporation | $258.36 | 2019-2025 | Therasphere Administration Set, Spyglass Discover |
| B. Braun Interventional Systems INC. | $180.80 | 2022-2025 | Celsite |
| Penumbra, INC. | $62.79 | 2025 | Indigo System |
| Medtronic, INC. | $61.29 | 2024-2025 | Abre, Onyx 18 |
| Cook Medical LLC | $45.95 | 2024-2025 | Cook, Rosch-Uchida, Torcon Nb |
| Ekos Corporation | $41.28 | 2019 | |
| Terumo Medical Corporation | $31.13 | 2024 | Glidesheath Slender, Angio-Seal, Azur Cx Detachable |
| Instylla, INC. | $13.50 | 2024 | Instylla Delivery Kit, Instylla Microcatheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Novelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.